Patents by Inventor Kaiji Hu

Kaiji Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF
    Publication number: 20240294514
    Abstract: Disclosed are compounds of Formula I that are useful as Monoacylglycerol lipase (MAGL) inhibitors These compounds may be used in pharmaceutical compositions, formulations, and methods for the treatment of disease states, disorders, and conditions benefited by the inhibition or modulation of MAGL activity, such as, but are not limited to, anxiety and mood disorder, metabolic disorder, a neurodegenerative disorder, mental disorder, brain disorder, pain, inflammatory disorder, cancer, Alzheimer's disease, movement disorders, epilepsy or stroke.
    Type: Application
    Filed: February 13, 2024
    Publication date: September 5, 2024
    Inventors: Safwat Mohamed RABEA, David Earl BOGUCKI, Kaiji HU
  • COMPOUNDS FOR TREATING PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) MEDIATED DISEASES OR CONDITIONS
    Publication number: 20220378744
    Abstract: Novel compounds, in particular novel peroxisome proliferator-activated receptor (PPAR) agonist compounds, are provided. Pharmaceutical formulations for treating PPAR mediated disorder or condition are also provided. The formulations may be a combination of cannabinoids and the PPAR agonist compounds. The PPAR mediated disorder or condition may include inflammation related diseases such as psoriasis, psoriatic arthritis and atopic dermatitis.
    Type: Application
    Filed: April 22, 2022
    Publication date: December 1, 2022
    Inventors: Safwat M. RABEA, Kaiji HU, Rakshit D. KODEKALRA, K.K. Durgaro VISHWANADHAM, Rashmi TIWARI-PANDEY, Nihar PANDEY
  • Macrolide compounds with antibiotic and antineoplastic properties
    Patent number: 8039454
    Abstract: The invention is drawn to novel macrolide compounds of formula I having antibiotic and antineoplastic activities, useful as medicaments and/or agrochemicals for microorganism infections, in particularly for infectious diseases involving drug-resistant Staphylococcus, and for treatment of human and animal cancers.
    Type: Grant
    Filed: November 28, 2006
    Date of Patent: October 18, 2011
    Assignee: Weihe Pharma{grave over (c)}euticals Co. Ltd.
    Inventors: Genhui Chen, Bin Li, John M. Webster, Kaiji Hu, Jianxiong Li
  • Novel Macrolide Compounds With Antibiotic and Antineoplastic Properties
    Publication number: 20090264644
    Abstract: The invention is drawn to novel macrolide compounds of formula I having antibiotic and antineoplastic activities, useful as medicaments and/or agrochemicals for microorganism infections, in particularly for infectious diseases involving drug-resistant Staphylococcus, and for treatment of human and animal cancers.
    Type: Application
    Filed: November 28, 2006
    Publication date: October 22, 2009
    Inventors: Genhui Chen, Bin Li, John M. Webster, Kaiji Hu, Jianxiong Li
  • Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
    Publication number: 20030171429
    Abstract: Disclosed herein are compositions containing hydroxylstilbenes or their derivatives or analogues. The compositions are useful to inhibit protein kinease, and for the treatment of inflammatory diseases, including psoriasis, multiple sclerosis, rhumatoid arthritis, restinosis, inflammatory bowel disease, and inflammatory lung disease. They are also useful to treat surgical adhesions and graft rejection. Novel derivatives and analogues are also disclosed.
    Type: Application
    Filed: October 28, 2002
    Publication date: September 11, 2003
    Inventors: Genhui Chen, John M. Webster, Jianxiong Li, Kaiji Hu, Jiang Zhu